Kinetoplastida
Kinetoplastida is an order of protozoa that includes a variety of species known to cause serious diseases in humans, as well as in other animals and plants. The most notable diseases caused by Kinetoplastida include Sleeping sickness, transmitted by the Tsetse fly, and Chagas disease, transmitted by the Triatominae insect. These diseases are primarily found in tropical and subtropical regions. The Kinetoplastida are characterized by the presence of a kinetoplast, a unique structure within their mitochondrion that contains a large mass of DNA.
Characteristics[edit]
Kinetoplastida are unicellular, flagellated protozoans. The defining feature of the group is the kinetoplast, which is a specialized part of the mitochondrion. This kinetoplast contains circular DNA molecules, which are involved in the regulation of mitochondrial function. The organisms exhibit a variety of life cycle stages, including amastigote, promastigote, epimastigote, and trypomastigote forms, depending on the species and its environment.
Classification[edit]
The order Kinetoplastida is divided into two main families: Trypanosomatidae and Bodonidae. The Trypanosomatidae family includes the genera Trypanosoma and Leishmania, both of which are significant as human pathogens causing sleeping sickness and leishmaniasis, respectively. The Bodonidae family includes free-living species as well as parasites of invertebrates.
Pathogenesis[edit]
The pathogenic species within the Kinetoplastida are responsible for significant morbidity and mortality in affected populations. Trypanosoma brucei, for example, causes sleeping sickness in humans and nagana in animals, primarily in sub-Saharan Africa. Trypanosoma cruzi is the causative agent of Chagas disease, prevalent in Latin America. Leishmania species cause leishmaniasis, which manifests in several forms, ranging from cutaneous to visceral disease.
Diagnosis and Treatment[edit]
Diagnosis of diseases caused by Kinetoplastida involves the detection of the parasite in tissue, blood, or other body fluids, often using microscopy, serological tests, or molecular methods. Treatment depends on the specific disease and may include drugs such as pentavalent antimonials for leishmaniasis, nifurtimox, and benznidazole for Chagas disease, and various drugs for sleeping sickness, including pentamidine, suramin, and eflornithine.
Epidemiology[edit]
The diseases caused by Kinetoplastida have a significant impact on public health in endemic regions. Sleeping sickness and Chagas disease are both considered neglected tropical diseases, with millions of people at risk. Control measures include vector control, screening of blood donations, and treatment of infected individuals.
Research and Development[edit]
Research into Kinetoplastida and the diseases they cause is focused on understanding the biology of the parasites, their interaction with hosts, and the development of new diagnostic methods and treatments. Vaccine development is an area of interest, although no vaccines are currently available for human use against these diseases.
Conclusion[edit]
Kinetoplastida are a group of protozoa that include important pathogens affecting humans and animals. The diseases caused by these organisms, such as sleeping sickness, Chagas disease, and leishmaniasis, pose significant challenges for public health in endemic regions. Continued research and development efforts are crucial for improving diagnosis, treatment, and control measures for these diseases.
Kinetoplastida[edit]
-
Kinetoplastida
-
Bodo saltans at 400x magnification
-
Trypanosoma species
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian